Skip to content
DraconiticResearch
Search Sources API
197,788 studies31 sourcesUpdated 27 min ago
PreprintAll rights reservedmedRxiv

CD3-engaging bispecific antibodies convert human regulatory T cells into cytotoxic effectors

  • J. J. Michel
  • J. H. Frenking
  • A. Metzler
  • A. Schach
  • E. Meermeier
  • V. Thiel
  • N. Kehl
  • J. Zoller
  • S. Cuntz
  • C. Funk
  • R. Onken
  • A. Kirschner
14 more authors
  • S. Huhn
  • A. Brobeil
  • A. Trumpp
  • M. Rahbari
  • M. Heikenwaelder
  • C. Mueller-Tidow
  • L. Bergsagel
  • H. Goldschmidt
  • H. Einsele
  • L. Rasche
  • M. Chesi
  • M. Raab
  • N. Weinhold
  • M. J. Friedrich1
  1. 1German Cancer Research Institute Heidelberg JRG Hematology and Immune Engineering
Read full textPDFDOICite

Related

  1. Engineering T cell-engaging bispecific antibodies targeting KRAS G12V neoantigen across HLA-A*11:01 and HLA-A*03:01.
    Xiaojing Wu, Clara Effenberger, Yosuke Matsushita +7
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textMedical imaging & radiologyEurope PMC
  2. Neurologist-focused workflows for immune effector cell-associated neurotoxicity syndrome in CAR T-cell therapy and CD3-engaging bispecific antibodies
    Walid Alesefir, Mariam Hejazi, Basil Alashger +6
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  3. Non‐Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis
    Sohaib Irfan, Harshit Khosla, Saad Nasir +5
    Hematological oncologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Infection-related adverse events associated with T-cell-engaging bispecific agents: A real-world pharmacovigilance study using FAERS/AEMS
    Shui Liu, Ye Tan, Aidong Chen +1
    International Journal of Immunopathology and PharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  5. LIF and let die: Generation, mechanistical and structural characterization of bispecific antibodies triggering leukemia inhibitory factor (LIF) receptor activation independent of the cytokine LIF
    Julia Harwardt, Silke Pudewell, Kristina Keil +12
    Journal of Biological ChemistryPeer-reviewedCC BY 4.0OncologyCrossref

Cite

BibTeXRIS
BibTeX
@misc{michel2026cd3engaging,
  title = {{CD3-engaging bispecific antibodies convert human regulatory T cells into cytotoxic effectors}},
  author = {J. J. Michel and J. H. Frenking and A. Metzler and A. Schach and E. Meermeier and V. Thiel and N. Kehl and J. Zoller and S. Cuntz and C. Funk and R. Onken and A. Kirschner and S. Huhn and A. Brobeil and A. Trumpp and M. Rahbari and M. Heikenwaelder and C. Mueller-Tidow and L. Bergsagel and H. Goldschmidt and H. Einsele and L. Rasche and M. Chesi and M. Raab and N. Weinhold and M. J. Friedrich},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.23.26363285},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.23.26363285v1},
}
RIS
TY  - UNPB
TI  - CD3-engaging bispecific antibodies convert human regulatory T cells into cytotoxic effectors
AU  - J. J. Michel
AU  - J. H. Frenking
AU  - A. Metzler
AU  - A. Schach
AU  - E. Meermeier
AU  - V. Thiel
AU  - N. Kehl
AU  - J. Zoller
AU  - S. Cuntz
AU  - C. Funk
AU  - R. Onken
AU  - A. Kirschner
AU  - S. Huhn
AU  - A. Brobeil
AU  - A. Trumpp
AU  - M. Rahbari
AU  - M. Heikenwaelder
AU  - C. Mueller-Tidow
AU  - L. Bergsagel
AU  - H. Goldschmidt
AU  - H. Einsele
AU  - L. Rasche
AU  - M. Chesi
AU  - M. Raab
AU  - N. Weinhold
AU  - M. J. Friedrich
PY  - 2026
DA  - 2026/09/23
PB  - medRxiv
DO  - 10.64898/2026.09.23.26363285
UR  - https://www.medrxiv.org/content/10.64898/2026.09.23.26363285v1
ER  -